Qed Therapeutics
Qed Therapeutics is a small Molecule Targeting Tyrosine Kinase Receptors founded in 2018.
Industries
Qed Therapeutics is active in the following industries:
Qed Therapeutics is a small Molecule Targeting Tyrosine Kinase Receptors founded in 2018.